Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0C9FF
|
||||
| Former ID |
DCL000776
|
||||
| Drug Name |
DNK-333
|
||||
| Synonyms |
DNK 333; DNK333; N-((R,R)-(E)-1-(3,4-Dichlorobenzyl)-3-(2-oxoazepan-3-yl)carbamoyl)allyl-N-methyl-3,5-bis(trifluoromethyl)benzamide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Irritable bowel syndrome with diarrhoea [ICD9: 493, 564.1, 787.91; ICD10:A09, J45, K58, K59.1] | Discontinued in Phase 2 | [536223] | ||
| Company |
Novartis
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C27H25Cl2F6N3O3
|
||||
| Canonical SMILES |
CN(C(CC1=CC(=C(C=C1)Cl)Cl)C=CC(=O)NC2CCCCNC2=O)C(=O)C3=<br />CC(=CC(=C3)C(F)(F)F)C(F)(F)F
|
||||
| InChI |
1S/C27H25Cl2F6N3O3/c1-38(25(41)16-12-17(26(30,31)32)14-18(13-16)27(33,34)35)19(10-15-5-7-20(28)21(29)11-15)6-8-23(39)37-22-4-2-3-9-36-24(22)40/h5-8,11-14,19,22H,2-4,9-10H2,1H3,(H,36,40)(H,37,39)/b8-6+/t19-,22?/m0/s1
|
||||
| InChIKey |
BHCJHYIMNHXLOM-PBWXKQKBSA-N
|
||||
| CAS Number |
CAS 203932-02-9
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Substance-P receptor | Target Info | Modulator | ||
| NK-2 receptor | Target Info | Modulator | |||
| PANTHER Pathway | CCKR signaling map ST | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.